Glen pharma share price
Glenmark Pharma stock or share prices, Live BSE/NSE, F&O Quotes of Glenmark Pharma with historic price charts for NSE / BSE. Get Glenmark Pharma buy sell Get complete details on Glenmark Pharmaceuticals Ltd. share price data, company profile data, company news, intraday charts, EOD charts, financial data, peer View live GLENMARK PHARM chart to track its stock's price action. Glenmark is share which rebounces to fibbonacci 0.5 from bottom after long down trend , consolidation it is GLENMARK (Glenmark Pharmaceuticals Ltd)BUY ABOVE 336. Industry:Pharma; Market cap:Rs 6,788.00 Cr (Mid Cap); P/E: 10.20Industry P/E: 28.20Dividend Yield: 0.77%Debt Equity: 0.44; Net Sales: Rs 2,735.56 crNet Latest Glenmark Pharmaceuticals Ltd (GLENMARK:NSI) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile
Glenmark Pharmaceuticals Ltd. Stock/Share prices today, Glenmark Pharmaceuticals Ltd. Live BSE/NSE. Get details on Glenmark Pharmaceuticals Ltd. news,
RSS stands for Really Simple Syndication. RSS feed is a XML file that provides summaries, including links to the full versions of the content.It is available through RSS feed reader or through some browsers. Glenmark Pharmaceuticals Ltd. key Products/Revenue Segments include Pharmaceuticals which contributed Rs 6072.35 Crore to Sales Value (96.31 % of Total Sales), Other Operating Revenue which contributed Rs 173.73 Crore to Sales Value (2.75 % of Total Sales) and Sale of services which contributed Rs 58.79 Crore to Sales Value (0.93 % of Total Sales)for the year ending 31-Mar-2019. Glenmark Pharmaceuticals up by 0.78% is trading at ₹ 219.50 today. Get live share price chart, key metrics, forecast and ratings of Glenmark Pharmaceuticals Ltd - GLENMARK on Tickertape GLENMARK Share Price - Glenmark Pharmaceuticals Limited NSE INDIA Technical Analysis, Target, Important Levels, Latest News, Interactive Charts. Tomorrow's share price targets for Glenmark Pharmaceuticals Limited are 392.5 and 395.67 on the upside. More share price targets here - Intraday, weekly and monthly price targets Short-term, Long-term forecast for Glenmark Pharmaceuticals Limited NEWS for Glenmark Pharmaceuticals Limited.
Glenmark Pharma Share Price Live - 215.50, Glenmark Pharma Stock Price, Today - The Economic Times.
Glenmark Pharmaceuticals Ltd. key Products/Revenue Segments include Pharmaceuticals which contributed Rs 6072.35 Crore to Sales Value (96.31 % of Total Sales), Other Operating Revenue which contributed Rs 173.73 Crore to Sales Value (2.75 % of Total Sales) and Sale of services which contributed Rs 58.79 Crore to Sales Value (0.93 % of Total Sales)for the year ending 31-Mar-2019. Glenmark Pharmaceuticals up by 0.78% is trading at ₹ 219.50 today. Get live share price chart, key metrics, forecast and ratings of Glenmark Pharmaceuticals Ltd - GLENMARK on Tickertape
For the year ending June 2019 Glenmark Pharma has declared an equity dividend of 200.00% amounting to Rs 2 per share. At the current share price of Rs 280.20 this results in a dividend yield of 0.71%. The company has a good dividend track report and has consistently declared dividends for the last 5 years.
Glenmark Pharma Share Price, Stock Analysis of Glenmark Pharma, Future Prospects, experts view on buy/sell/hold Glenmark Pharmaceuticals Ltd. shares. Glenmark Pharma stock or share prices, Live BSE/NSE, F&O Quotes of Glenmark Pharma with historic price charts for NSE / BSE. Get Glenmark Pharma buy sell Get complete details on Glenmark Pharmaceuticals Ltd. share price data, company profile data, company news, intraday charts, EOD charts, financial data, peer
For the year ending June 2019 Glenmark Pharma has declared an equity dividend of 200.00% amounting to Rs 2 per share. At the current share price of Rs 280.20 this results in a dividend yield of 0.71%. The company has a good dividend track report and has consistently declared dividends for the last 5 years.
Share market update: BSE Midcap index down; Glenmark Pharma plunges 21% - 5 day(s) ago GLENMARK PHARMA Surges by 12%; BSE HEALTHCARE Index Down 0.3% - 1 day(s) ago Glenmark Q3 net profit rises 64% to Rs 190.83 cr; to raise $400 mn - 14 Feb 2020
View live GLENMARK PHARM chart to track its stock's price action. Glenmark is share which rebounces to fibbonacci 0.5 from bottom after long down trend , consolidation it is GLENMARK (Glenmark Pharmaceuticals Ltd)BUY ABOVE 336. Industry:Pharma; Market cap:Rs 6,788.00 Cr (Mid Cap); P/E: 10.20Industry P/E: 28.20Dividend Yield: 0.77%Debt Equity: 0.44; Net Sales: Rs 2,735.56 crNet